Chemoinformaics analysis of 8-ISOBUTYRYLOXY ISOBORNYL ISOBUTYRATE
| Molecular Weight | 310.434 | nRot | 5 |
| Heavy Atom Molecular Weight | 280.194 | nRig | 10 |
| Exact Molecular Weight | 310.214 | nRing | 2 |
| Solubility: LogS | -4.577 | nHRing | 0 |
| Solubility: LogP | 4.092 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 53.2718 |
| nHD | 0 | BPOL | 35.3042 |
| QED | 0.728 |
| Synth | 4.747 |
| Natural Product Likeliness | 1.953 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0 |
| HIA | 0.013 |
| CACO-2 | -4.783 |
| MDCK | 0.0000232 |
| BBB | 0.699 |
| PPB | 0.835065 |
| VDSS | 1.169 |
| FU | 0.219299 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.291 |
| CYP2c19-inh | 0.168 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.183 |
| CYP2c9-sub | 0.168 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.502 |
| CYP3a4-sub | 0.496 |
| CL | 8.239 |
| T12 | 0.161 |
| hERG | 0.014 |
| Ames | 0.015 |
| ROA | 0.047 |
| SkinSen | 0.456 |
| Carcinogencity | 0.1 |
| EI | 0.255 |
| Respiratory | 0.125 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.816654 |